McDowell Caryn Gordon 4
4 · Revance Therapeutics, Inc. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-01-24+50,000→ 50,000 totalExercise: $17.23Exp: 2029-01-23→ Common Stock (50,000 underlying) - Award
Common Stock
2019-01-24+7,500→ 24,318 total
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 24, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Plan) on each vesting date.